Page last updated: 2024-08-26

s-nitrosoglutathione and Periodontal Diseases

s-nitrosoglutathione has been researched along with Periodontal Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baldim, V; Bonfim, LE; Brito, GA; Costa, DV; G de Oliveira, M; Leitão, RF; Lima, V; Martins, CS; Melo, CB; Melo, IM; Santos, GS; Wong, DV	1

Other Studies

1 other study(ies) available for s-nitrosoglutathione and Periodontal Diseases

Article	Year
Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats. PloS one, 2016, Volume: 11, Issue:4 Topics: Administration, Topical; Alveolar Bone Loss; Animals; Disease Models, Animal; Gingiva; Hypromellose Derivatives; Inflammation; Interleukin-1beta; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Periodontal Diseases; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; S-Nitrosoglutathione; Solutions; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha	2016

Article

Year

Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats.

PloS one, 2016, Volume: 11, Issue:4

Topics: Administration, Topical; Alveolar Bone Loss; Animals; Disease Models, Animal; Gingiva; Hypromellose Derivatives; Inflammation; Interleukin-1beta; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Periodontal Diseases; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; S-Nitrosoglutathione; Solutions; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha

2016